Rare diseases
Investigational molecules
Locations
Back to Portugal673 clinical trials in Almada, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy
PortugalStudy on the Effects of GV1001 for Patients with Mild to Moderate Alzheimer's Disease
PortugalStudy on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
PortugalStudy on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients
PortugalStudy on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4
PortugalStudy on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis
PortugalStudy of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels
PortugalStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
PortugalStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
PortugalStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
PortugalStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
PortugalStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
PortugalThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on pulmonary arterial hypertension and chronic obstructive pulmonary disease, evaluating novel treatments including ralinepag and itepekimab for long-term management of these conditions.
Research investigating treatments for systemic lupus erythematosus, rheumatoid arthritis, and other inflammatory conditions, with studies on medications like upadacitinib and remibrutinib.
Studies examining treatments for multiple sclerosis, migraine prevention, and neurological conditions, testing medications such as ocrelizumab and atogepant.
Investigations into hypertrophic cardiomyopathy and stroke prevention, studying treatments like mavacamten and asundexian for improved cardiac outcomes.
Advanced studies in lung cancer, colorectal cancer, and head and neck cancers, evaluating novel immunotherapy combinations and targeted treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
